Zdrowie i gospodarka · 31/10/2006

FDA Proposes to Reclassify Absorbable Hemostatic Device

The Food and Drug Administration (FDA) is proposing to move the absorbable hemostatic device from a class III device requiring premarket approval to a class II device with special controls, in accordance with the Federal Food, Drug, and Cosmetic Act.